Industry reports
Editor highlights

CytRx Market and Forecasts, April 2014

You might be interested in: drug


 

» View Public Reports

1-2 of 2 reports for CytRx

Drug Sector in Japan

  • Industry report
  • June 2012
  • 3 pages

... Licensed-out to: cytrx corporation (usa) preparation preparation hematologic malignancies hematologic malignancies potent inhibitor of bcr-abl and lyn tyrosine kinases. Possibly ef_fective in imatinib ...

Drug Sector in Japan

  • Industry report
  • September 2012
  • 3 pages

... With increased efficacy and reduced side effects. Ns-187 (bafetinib) b-cell chronic lymphoid leukemia chronic myeloid leukemia (pii preparation) nippon shinyakupii licensed-out to: cytrx corporation (usa ...



ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.